Dr Thomas Hecht
Chairman
Cell Medica.
United Kingdom
Biography
Thomas is Chairman of the Board since 2012. He was previously Vice President Marketing at Amgen Europe, Lucerne, Switzerland. Following his academic career, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany. Today, he provides services to the pharmaceutical industry in clinical development/ marketing and licensing strategies. He also serves as Chairman of Affimed NV, Vaximm AG and Aelix Therapeutics SA. In 2009, with the acquisition by Alcon, he stepped down as Chairman of ESBATech AG; and in 2015, with the acquisition by Baxter International Inc., from his post as Chairman of the Supervisory Council of SuppreMol GmbH. Thomas earned his MD at the University of Freiburg.
Research Interest
Clinical Sciences.
